Loading...
Smooth muscle-specific drug targets for next generation Drug-eluting stent
The occurrence of stent thrombosis is one of the major obstacles limiting the long-term clinical efficacy of percutaneous coronary intervention. The anti-smooth muscle proliferation drugs coated on drug-eluting stents (DES) often indistinguishably block re-endothelialization, an essential step towar...
Na minha lista:
| Udgivet i: | Expert Rev Cardiovasc Ther |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4358302/ https://ncbi.nlm.nih.gov/pubmed/24325297 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/14779072.2014.866518 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|